🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral semaglutide bioavailability optimization — 12 month update Page 6

Oral semaglutide bioavailability optimization — 12 month update

jim_asheville Wed, Feb 7, 2024 at 4:58 PM 58 replies 3,516 viewsPage 6 of 12
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Feb 27, 2024 at 8:24 PM#26

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

39 14labquiet_amy, emily_PDX, Dr.SleepRoch and 36 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Mar 1, 2024 at 7:45 AM#27
carl_compliance said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This matches mine closely enough to be worth saying so out loud. Posting only so the count is not one.

38 13raj_cambridge, ingrid_STO, pete_nash and 35 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Mar 3, 2024 at 7:07 PM#28
carl_compliance said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

Correct me if the detail matters more than I have assumed.

37 12greg_boulder, quinn_sf, NurseLeah_Nash and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Mar 6, 2024 at 6:31 AM#29

The figures, for anyone assembling their own picture. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

36 11SandraNC_45, Dr.EndoIndy, tom_AK and 33 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Mar 8, 2024 at 5:56 PM#30

Closing the loop on my own question.

Following this thread I went back and re-read the extension data properly. The point about trough rather than peak explains the pattern I was seeing on day six, which I had been blaming on the vial.

14 14LarryQC_SD, wanda_boise, NurseAsh_DET and 11 others
Reply Quote Save Share Report
14567812

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register